tiprankstipranks
Trending News
More News >
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (DE:2TZ)
FRANKFURT:2TZ

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (2TZ) Revenue

Compare
0 Followers

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Revenue

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S had a revenue of 1.65B in the quarter ending Sep 30, 2024, with -12.40%. This bring the company's revenue in the last twelve months to 8.04B, Increased -0.72%. In the fiscal year ending Dec 31, 2023, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S had annual revenue of 8.22B with -0.33% growth.
Revenue (ttm)
8.04B
Revenue Growth
P/S Ratio
0.45
Revenue/Employee
€1,673,583
Employees
4,913
Market Cap
€3.68B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023
8.22B-26.94M+99.67%
Dec 31, 2022
8.25B1.34B+119.42%
Dec 31, 2021
6.91B303.89M+104.60%
Dec 31, 2020
6.60B-390.23M+94.42%
Dec 31, 2019
6.99B635.26M+109.99%
Dec 31, 2018
6.36B